
March 25 (Reuters) - Corcept Therapeutics shares jumped more than 32% to nearly a two-month high on Wednesday after the U.S. health regulator approved its lead drug for treating an aggressive form of ovarian cancer that no longer responds to standard treatment.
The U.S. Food and Drug Administration approved relacorilant, brand name Lifyorli, for use in combination with the chemotherapy drug nab-paclitaxel.
The therapy is cleared for adults with platinum-resistant epithelial ovarian cancer, a type that returns or progresses within about six months of platinum-based chemotherapy.
Lifyorli works by blocking cortisol-related stress signals in the body, a mechanism that can make cancer cells more responsive to chemotherapy.
The approval was based on a late-stage trial involving 381 patients. The data showed those treated with the combination lived a median of 16 months, compared with 11.9 months for patients receiving chemotherapy alone.
Patients are advised to take 150 mg of the drug on the day before, the day of, and the day after each infusion of nab-paclitaxel, the FDA said.
The treatment carries warnings for low white blood cell counts, serious infections, adrenal insufficiency and potential harm to unborn babies, and should not be used in patients who rely on steroid medications to survive.
UBS analyst Ashwani Verma viewed the approval, which came three months ahead of schedule, as a positive, but said a contraindication for patients on steroid medications could be a hurdle and estimated its peak sales of about $550 million.
In December, the FDA had declined to approve relacorilant for hypertension linked to Cushing's syndrome, saying the drug failed to outperform a placebo and raised concerns about potential liver injury — a setback that sent the company's shares plunging about 50%.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Devika Syamnath and Shilpi Majumdar)
latest_posts
- 1
Step by step instructions to Protect Your Retirement with Senior Protection. - 2
Novo Nordisk slashes prices of popular weight loss and diabetes drugs - 3
Most normal matter in the universe isn't found in planets, stars or galaxies – an astronomer explains where it's distributed - 4
Step by step instructions to Prepare with Senior Protection for Inward feeling of harmony. - 5
West Palm Beach Shorecrest, renderings of downtown waterfront condo
The most effective method to Amplify Your Opportunity for growth in a Web-based Degree Program
How Trump's marijuana executive order could change medical research landscape
You finally got a doctor's appointment. Here's how to get the most out of it
NI economy losing momentum due to Iran crisis
Key takeaways from Sen. Bill Cassidy's interview on 'Face the Nation' with Margaret Brennan
Vote in favor of Your #1 4K television: Lucidity and Drenching Matter
Are Iraqi militias crossing into Iran to support Iran's war effort?
NASA releases new ‘Earthset’ and eclipse images taken during historic flyby of the moon
Understanding the Rudiments of Tree Administrations













